MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Subscribe To Our Newsletter & Stay Updated
